CS logo
small CS logo
Blacktown Cancer and Haematology Centre

Blacktown, New South Wales, Australia
Hospital in Blacktown, New South Wales
18 Blacktown Rd, Blacktown NSW 2148

About Blacktown Cancer and Haematology Centre


Blacktown Hospital is an acute care hospital in Blacktown, New South Wales, Australia, about 34 kilometres from the Sydney CBD. Together with Mount Druitt Hospital and associated community health centres, it is a part of the Western Sydney Local Health District.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BeiGene
3
Bayer
2
Incyte Biosciences International Sàrl
1
Panbela Therapeutics, Inc.
1
Total Rows: 4

Clinical Trials at Blacktown Cancer and Haematology Centre


During the past decade, Blacktown Cancer and Haematology Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112222110011000000000000Started TrialsCompleted Trails2016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
2016-09-07
2019-08-05
Completed
63
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors
2017-05-26
2021-07-26
Completed
173
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
2017-04-25
2021-11-09
Completed
145
Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
2018-06-04
2022-02-28
Completed
50
A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Patients With Advanced Solid Tumors.
2018-11-01
2023-01-05
Completed
216
Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors
2019-05-01
2024-04-29
Recruiting
105
Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2021-07-27
2024-06-30
Recruiting
420

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Blacktown Cancer and Haematology Centre" #1 collaborator was "ImmunoGen, Inc." with 1 trials as a collaborator, "MorphoSys AG" with 1 trials as a collaborator and "SpringWorks Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBeiGene: 3BeiGene: 3Bayer: 2Bayer: 2Incyte BiosciencesInternational Sàrl: 1Incyte BiosciencesInternational Sàrl: 1Panbela Therapeutics, Inc.: 1Panbela Therapeutics, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsImmunoGen, Inc.: 1ImmunoGen, Inc.: 1MorphoSys AG: 1MorphoSys AG: 1SpringWorksTherapeutics, Inc.: 1SpringWorksTherapeutics, Inc.: 1

Clinical Trials Conditions at Blacktown Cancer and Haematology Centre


According to Clinical.Site data, the most researched conditions in "Blacktown Cancer and Haematology Centre" are "Advanced Malignancies" (1 trials), "Advanced Solid Tumors" (1 trials), "Medical Oncology" (1 trials), "Metastatic Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Blacktown Cancer and Haematology Centre" in a lesser frequency.

Clinical Trials Intervention Types at Blacktown Cancer and Haematology Centre


Most popular intervention types in "Blacktown Cancer and Haematology Centre" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Anetumab ravtansine (BAY94-9343)" (2 trials), "Sitravatinib" (2 trials), "Tislelizumab" (2 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Blacktown Cancer and Haematology Centre


The vast majority of trials in "Blacktown Cancer and Haematology Centre" are 7 trials for "All" genders.

Clinical Trials Status at Blacktown Cancer and Haematology Centre


Currently, there are NaN active trials in "Blacktown Cancer and Haematology Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Blacktown Cancer and Haematology Centre, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Blacktown Cancer and Haematology Centre, 6 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 6Phase 1: 6Phase 2: 2Phase 2: 2Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 2Recruiting: 2

Departments of Blacktown Cancer and Haematology Centre


Blacktown Cancer and Haematology Centre has several departments that took part in Clinical trials: "Westmead Hospital; Medical Oncology and Pallative Care" - 10 trials
Departments List
Total Rows: 1